Helen Palmer
Latest Stories (187)
Medicare payment cuts
by
Helen Palmer
Aug 9, 2006
Beginning next year, doctors will see a cut in Medicare reimbursements — all part of the government overhaul of the Medicare payment system. But how will it affect hospital-goers? Helen Palmer reports.
Pharma-merger
by
Helen Palmer
Aug 8, 2006
Two of the nation's biggest institutional pharmacy suppliers are merging, and the move could be good for consumers. Helen Palmer looks at the implications of the merger.
Prescription for Bid Rx: Drug buying options
by
Helen Palmer
Aug 4, 2006
A new website hopes to do for prescription drugs what eBay did for auctions. Helen Palmer reports.
Dissatisfied with Medicare Part D
by
Helen Palmer
Aug 2, 2006
A new survey shows 70 percent of users are dissatisfied with the government's Medicare Part D program. Helen Palmer reports.
Cancer drug warning
by
Helen Palmer
Jul 24, 2006
New research shows a group of popular cancer drugs can increase risk of heart attack, but the findings may do little to dampen sales. Helen Palmer reports.
Mad cow testing scaled back
by
Helen Palmer
Jul 20, 2006
The Department of Agriculture isn't too worried about mad cow disease. It's sharply cutting the number of cattle it tests. Helen Palmer reports.
Scaling back mad cow inspections
by
Helen Palmer
Jul 20, 2006
The US Department of Agriculture is expected to announce today that it's scaling back inspections of American cattle for signs of mad cow disease. Some cattlemen think that's a mistake, Helen Palmer reports.
Immigrants, uninsured not flooding ERs
by
Helen Palmer
Jul 18, 2006
A new study dispels the commonly-held belief that immigrants use emergency room services more than other groups. Helen Palmer has the story.
It's 'Doughnut Hole Day'
by
Helen Palmer
Jul 18, 2006
Democrats today are highlighting Medicare's "Doughnut Hole" coverage gap, but there's disagreement over just how many people will actually fall into the hole. Helen Palmer reports.
Another win in Merck's column
by
Helen Palmer
Jul 14, 2006
With yesterday's verdict in New Jersey, Merck has now won more than half of the Vioxx liability lawsuits filed against it. Is the decision to fight individual cases paying off? Helen Palmer reports.